Top Markets
#1 B3 (Base) B3 (Base) +15.03%
#2 Siacoin Siacoin +7.20%
#3 OriginTrail OriginTrail +6.85%
#4 Kaia Kaia +5.91%
#5 The Black Bull The Black Bull +5.74%
#6 TROLL TROLL +5.48%
#7 Movement Movement +5.04%
#8 BORA BORA +4.90%
#9 MVL MVL +4.09%
#10 Moo Deng Moo Deng +3.52%
Coin of the day
B3 (Base) B3 (Base)
設定
言語
日本
通貨
USD
テーマ
BRIM Biotechnology, Inc. BRIM Biotechnology, Inc.

BRIM Biotechnology, Inc.

6885
株式のランク #22414
BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing... BRIM Biotechnology, Inc., a clinical-stage firm, specializes in developing innovative regenerative therapies to address both ophthalmic and degenerative joint conditions. Leading its pipeline is BRM 421, a topical ophthalmic solution designed to treat moderate-to-severe dry eye syndrome, which has successfully completed a Phase 2 clinical trial in the United States. The company's development efforts also encompass BRM 423, currently in Phase 1 clinical trials for severe corneal damage; BRM 424, also in Phase 1, targeting neurotrophic keratitis; and BRM 521, which aims to alleviate and repair tissue damage caused by osteoarthritis. Founded in 2013, BRIM Biotechnology is headquartered in Taipei, Taiwan.
株価
$0.66936954
最終同期: 2026-07-28
時価総額
$89.04M
変化（1日）
0.00%
変化（1年）
-40.10%
国
TW
取引 BRIM Biotechnology, Inc. (6885)

カテゴリー

Healthcare
BRIM Biotechnology, Inc.（6885）のP/S比率
2026 時点のP/S比率 TTM: 0
BRIM Biotechnology, Inc. の最新の財務報告および株価によると、現在のP/S比率（TTM）は 0 です。2026 年末時点でのP/S比率は 0 でした。
BRIM Biotechnology, Inc. の P/S 比率の履歴（2026 ～ 2026）
各年末時点のP/S比率
年 P/S比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/S比率
企業 P/S比率 P/S比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH